Company News in the Life Science Industry

»

Reset 

Mustang Bio Announces Opening of CAR T Cell Therapy Manufacturing Facility in Worcester, Mass.

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Endocyte Announces Presentations on PSMA-617 at the 2018 Society of Nuclear Medicine and Molecular Imaging Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Syneos Health to Share Strategies Designed to Meet the Needs of Patients, Payers and Regulators at DIA Global Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Matinas BioPharma Announces Closing of $8.0 Million Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Ordinary General Meeting of Shareholders of Probiodrug AG

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Adamas Presents New Data Analysis Demonstrating that GOCOVRI™ Reduces Transitions between Dyskinesia and OFF Episodes Throughout the Day

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Clinical Overview of PrabotulinumtoxinA for the Investigational Treatment of Frown Lines to Be Featured During Summer Cosmetic Bootcamp 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

LumiThera LT-300 Device For Treating Dry Advanced Macular Degeneration Granted CE Mark

SEATTLE, June 22, 2018 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company focused on developing non-invasive Photobiomodulation (PBM) therapies for ocular disorders and disease, announced CE Mark Certification for the European Union (EU) for the treatment of dry age-related... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2018
Related companies:  LumiThera, Inc.

Mallinckrodt plc To Report Earnings Results For Second Quarter Of Fiscal 2018

STAINES-UPON-THAMES, United Kingdom, June 22, 2018 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, announced today that it will report fiscal 2018 second quarter earnings results,... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2018
Related companies:  Mallinckrodt Plc

Replimune Appoints Dieter K. Weinand to Board of Directors

WOBURN, Massachusetts, June 22, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Jun 2018

Global Eyeglasses (Lenses, Frames & Sunglasses) Markets 2016-2018 & 2024: Profiles of 250+ Companies Including many Key Players

DUBLIN, June 22, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Jun 2018

ImaginAb Reconstitutes Japanese Subsidiary

LOS ANGELES and TOKYO, June 22, 2018 /PRNewswire/ -- ImaginAb, Inc. announced today new directors of ImaginAb Japan KK, a wholly-owned subsidiary of Los Angeles-based ImaginAb, Inc. Headquartered in Tokyo, the subsidiary's goal is to better realize partnering opportunities with Japanese pharmaceutical... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2018
Related companies:  ImaginAb, Inc.

Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine

SEATTLE, June 22, 2018 /PRNewswire/ -- Impel NeuroPharma, a Seattle-based, privately-held biotechnology company focused on therapies for the treatment of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it may... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2018
Related companies:  U.S. Food and Drug Administration | IMPEL NEUROPHARMA INC.

Lilly Completes Acquisition of ARMO BioSciences

INDIANAPOLIS, June 22, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of ARMO BioSciences, Inc. (NASDAQ: ARMO).

Read more ››
By: PR Newswire Association LLC. - 22 Jun 2018
Related companies:  Armo BioSciences, Inc. | Eli Lilly and Company

Righttime Medical Care and HeadFirst Concussion Care Welcome Chesapeake Neurology Associates

ANNAPOLIS, Md., June 22, 2018 /PRNewswire/ -- Rightime Medical Care is pleased to announce that renowned Maryland-based neurologist Harry G. Kerasidis, M.D., and his team at Chesapeake Neurology Associates have joined the urgent care company's HeadFirst Sports Injury and Concussion Care program.... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2018

GPB Capital Enters into $21 Million Debt Investment in CardioFocus®

NEW YORK, June 22, 2018 /PRNewswire/ -- GPB Capital has completed a debt investment in CardioFocus® Inc., which develops and manufactures products for the treatment of irregular heartbeats and other cardiac disorders. Proceeds from the investment will help CardioFocus commercially launch its... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2018
Related companies:  CardioFocus, Inc.

Canadian Cannabis Legalization Helps to Deter Illegal Markets

NEW YORK, June 22, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Jun 2018

William A. Haseltine, PhD Joins Grace Therapeutics' Board of Directors

EAST BRUNSWICK, N.J., June 22, 2018 /PRNewswire/ -- Grace Therapeutics, a clinical stage biopharmaceutical company focused on rare and orphan diseases, announced today that William Haseltine has been appointed to the company's Board of Directors. Dr. Haseltine is currently Chairman and President... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2018

Processa Pharmaceuticals Receives Orphan Designation Status For PCS499 In Necrobiosis Lipoidica From The Food And Drug Administration (FDA)

HANOVER, Md., June 22, 2018 /PRNewswire/ -- Processa Pharmaceuticals, Inc. (OTC: PCSA) a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have a high unmet medical need, announced today that the U.S. Food and Drug Administration... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2018
Related companies:  Processa Pharmaceuticals Inc.

Elizabeth O'Farrell Named to PDL BioPharma's Board of Directors

INCLINE VILLAGE, Nev., June 22, 2018 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) announced today that retired Eli Lilly and Company executive Elizabeth G. O'Farrell has been named to the Company's Board of Directors, effective June 22, 2018 and increasing the number... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2018
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies